F. Mayer

602 total citations
33 papers, 380 citations indexed

About

F. Mayer is a scholar working on Oncology, Reproductive Medicine and Surgery. According to data from OpenAlex, F. Mayer has authored 33 papers receiving a total of 380 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 15 papers in Reproductive Medicine and 13 papers in Surgery. Recurrent topics in F. Mayer's work include Ovarian cancer diagnosis and treatment (15 papers), Intraperitoneal and Appendiceal Malignancies (11 papers) and Cancer Treatment and Pharmacology (7 papers). F. Mayer is often cited by papers focused on Ovarian cancer diagnosis and treatment (15 papers), Intraperitoneal and Appendiceal Malignancies (11 papers) and Cancer Treatment and Pharmacology (7 papers). F. Mayer collaborates with scholars based in France, Germany and Luxembourg. F. Mayer's co-authors include B. Weber, D. Paraïso, Hugues Bourgeois, Éric Pujade-Lauraine, Hubert Orfeuvre, M. Combe, Bernard Leduc, D. Lepillé, Jean-­Marc Ferrero and C. Lhommé and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and European Journal of Cancer.

In The Last Decade

F. Mayer

32 papers receiving 363 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F. Mayer France 12 207 201 131 78 72 33 380
Regis J. Weiss United States 7 232 1.1× 217 1.1× 75 0.6× 26 0.3× 55 0.8× 9 387
Kyoko Nishikimi Japan 11 146 0.7× 161 0.8× 53 0.4× 49 0.6× 86 1.2× 46 290
Herbert Gretz United States 19 297 1.4× 405 2.0× 71 0.5× 69 0.9× 479 6.7× 33 779
M Moukhtar United States 13 92 0.4× 231 1.1× 63 0.5× 30 0.4× 201 2.8× 18 392
Heung-Tat Ng Taiwan 12 109 0.5× 224 1.1× 57 0.4× 44 0.6× 225 3.1× 16 453
Eriko Aotani Japan 10 209 1.0× 266 1.3× 120 0.9× 23 0.3× 74 1.0× 21 374
Sunamchok Srijaipracharoen Thailand 9 65 0.3× 118 0.6× 226 1.7× 42 0.5× 111 1.5× 20 373
Aeran Seol South Korea 9 81 0.4× 168 0.8× 47 0.4× 70 0.9× 149 2.1× 31 351
Lillian Yuri Kumagai Brazil 15 231 1.1× 170 0.8× 96 0.7× 28 0.4× 310 4.3× 41 501
M. Lahousen Austria 10 133 0.6× 195 1.0× 52 0.4× 14 0.2× 87 1.2× 27 307

Countries citing papers authored by F. Mayer

Since Specialization
Citations

This map shows the geographic impact of F. Mayer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Mayer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Mayer more than expected).

Fields of papers citing papers by F. Mayer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Mayer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Mayer. The network helps show where F. Mayer may publish in the future.

Co-authorship network of co-authors of F. Mayer

This figure shows the co-authorship network connecting the top 25 collaborators of F. Mayer. A scholar is included among the top collaborators of F. Mayer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Mayer. F. Mayer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rousselot, Hubert, F. Mayer, Éric Terrebonne, et al.. (2012). SALTO: a randomized, multicenter study assessing octreotide LAR in inoperable bowel obstruction. Bulletin du Cancer. 99(2). E1–E9. 31 indexed citations
2.
Hartmann, J. T., Sebastian Bauer, Gerlinde Egerer, et al.. (2012). Pemetrexed in patients with refractory soft tissue sarcoma: A non-comparative multicenter phase II study of the German Sarcoma Group AIO-STS 005. Investigational New Drugs. 31(1). 167–174. 3 indexed citations
3.
Guardiola, Emmanuel, Bruno Chauffert, Delphine Delroeux, et al.. (2010). Intraoperative chemotherapy with cisplatin and epinephrine after cytoreductive surgery in patients with recurrent ovarian cancer: a phase I study. Anti-Cancer Drugs. 21(3). 320–325. 11 indexed citations
4.
Kollmannsberger, Christian, Karin Oechsle, F. Mayer, et al.. (2010). Sunitinib in patients with multiply relapsed or cisplatin-refractory germ cell cancer: A CUOG/GTCSG cooperative phase II study.. Journal of Clinical Oncology. 28(15_suppl). 4582–4582. 4 indexed citations
5.
Tixier, Hervé, J. Fraisse, Bruno Chauffert, et al.. (2009). Evaluation of pelvic posterior exenteration in the management of advanced-stage ovarian cancer. Archives of Gynecology and Obstetrics. 281(3). 505–510. 14 indexed citations
6.
Joly, Florence, Thierry Petit, Patricia Pautier, et al.. (2009). Weekly combination of topotecan and gemcitabine in early recurrent ovarian cancer patients: A French multicenter phase II study. Gynecologic Oncology. 115(3). 382–388. 5 indexed citations
7.
Weber, B., Alain Lortholary, F. Mayer, et al.. (2009). Pegylated liposomal doxorubicin and carboplatin in late-relapsing ovarian cancer: a GINECO group phase II trial.. PubMed. 29(10). 4195–200. 19 indexed citations
8.
Favier, Laure, Nicolás Isambert, Sylvie Zanetta, et al.. (2007). Results of a phase I trial of intravenous vinorelbine plus oral capecitabine as first-line chemotherapy of metastatic breast cancer. The Breast. 17(1). 36–41. 6 indexed citations
9.
Fumoleau, P., et al.. (2007). [Targeting ErbB receptors in breast cancer].. PubMed. 94(7 Suppl). F147–70. 2 indexed citations
10.
Pautier, Patricia, Vincent Ribrag, Pierre Duvillard, et al.. (2007). Results of a prospective dose-intensive regimen in 27 patients with small cell carcinoma of the ovary of the hypercalcemic type. Annals of Oncology. 18(12). 1985–1989. 67 indexed citations
11.
Moluçon‐Chabrot, Cécile, Nicolás Isambert, L. Benoît, et al.. (2006). Feasibility of using intraperitoneal epinephrine and cisplatin in patients with advanced peritoneal carcinomatosis. Anti-Cancer Drugs. 17(10). 1211–1217. 12 indexed citations
12.
Ferrero, Jean-­Marc, B. Weber, J.-F. Geay, et al.. (2006). Second-line chemotherapy with pegylated liposomal doxorubicin and carboplatin is highly effective in patients with advanced ovarian cancer in late relapse: a GINECO phase II trial. Annals of Oncology. 18(2). 263–268. 86 indexed citations
13.
14.
Guastalla, Jean Paul, Jean Marc Ferrero, Alain Lortholary, et al.. (2004). A multicenter phase II study of cisplatin and docetaxel (Taxotere) in the first-line treatment of advanced ovarian cancer: a GINECO study. Cancer Chemotherapy and Pharmacology. 53(6). 489–495. 11 indexed citations
15.
Joly, Florence, Jean‐François Héron, Pierre Kerbrat, et al.. (2000). High-Dose Platinum versus Standard Dose in Advanced Ovarian Carcinoma: A Randomized Trial from the Gynecologic Cooperative Group of the French Comprehensive Cancer Centers (FNCLCC). Gynecologic Oncology. 78(3). 361–368. 18 indexed citations
16.
Hartmann, J.T., D. Quietzsch, Thomas Daikeler, et al.. (1999). Mitomycin C continuous infusion as salvage chemotherapy in pretreated patients with advanced gastric cancer. Anti-Cancer Drugs. 10(8). 729–734. 20 indexed citations
17.
Guastalla, Jean Paul, C. Lhommé, Pierre Kerbrat, et al.. (1994). Phase II trial of intraperitoneal carboplatin in ovarian carcinoma patients with macroscopic residual disease at second-look laparotomy. Annals of Oncology. 5(2). 127–132. 10 indexed citations
18.
Chauvergne, J, et al.. (1993). [Chemotherapy of cancers of the uterine cervix with a combination of bleomycin, mitomycin, cisplatin and etoposide].. PubMed. 80(1). 70–9. 4 indexed citations
19.
Héron, Jean‐François, C. Lhommé, Pierre Kerbrat, et al.. (1993). High dose chemotherapy in ovarian carcinoma. European Journal of Cancer. 29. S137–S137. 5 indexed citations
20.
Bechter, R., Marc Schmid, & F. Mayer. (1986). Teratogenic potential of antimycotic drugs evaluated in the whole-embryo culture system. Food and Chemical Toxicology. 24(6-7). 641–642. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Regis J. Weiss Breakdown of academic impact, for papers by Kyoko Nishikimi Breakdown of academic impact, for papers by Herbert Gretz Breakdown of academic impact, for papers by M Moukhtar Breakdown of academic impact, for papers by Heung-Tat Ng Breakdown of academic impact, for papers by Eriko Aotani Breakdown of academic impact, for papers by Sunamchok Srijaipracharoen Breakdown of academic impact, for papers by Aeran Seol Breakdown of academic impact, for papers by Lillian Yuri Kumagai Breakdown of academic impact, for papers by M. Lahousen
Rankless by CCL
2026